FindTrial
Sign In

To study the effect of Yavadi Lepa in Vyanga with special reference to Melasma

A RANDOMIZED CONTROLLED CLINICAL TRIAL TO STUDY THE EFFECT OF YAVADI LEPA IN VYANGA WITH SPECIAL REFERENCE TO MELASMA - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/09/073703
Enrollment
64
Registered
2024-09-10
Start date
Unknown
Completion date
Unknown
Last updated
2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L818- Other specified disorders of pigmentation

Interventions

None listed

Sponsors

Dr Vaishnavi Vijaykumar Jalihale
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Age -20 to 50 years of age Classical signs and symptoms of Vyanga like Mukhamagatya Mandalam circular patches on face. Shyavata(dark coloured) Kandu Daha. Symetric ,reticulated hyperpigmented patches with irregular borders present on centrofacial ,malar , mandibular region . Patients who will give consent for the use of drug

Exclusion criteria

Exclusion criteria: Vyanga caused due to any systemic disease eg- Dibeties,Cardiovascular disease ,Cushing syndrome Patients having another chronic skin disease Vyanga by birth (congenital) Patients with long term medication like blood thiner Pregnant women Immuno compramised disease. SLE

Design outcomes

Primary

MeasureTime frame
To evaluate the efficacy of Yavadi lepa on the signs and symptoms of vyangaTimepoint: 14days—

Secondary

MeasureTime frame
To study Where trial group is more effective than control groupTimepoint: 18 months—

Countries

India

Contacts

Public ContactDr Vaishnavi Vijaykumar Jalihale

SMBT Ayurved College and Hospital

rashmikurawar@gmail.com8793655354

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026